Amendment to Consulting Agreement, dated November 1, 2024, between Registrant and Stephen Thomas
Exhibit 10.2
Amendment to Consulting Agreement
This Amendment (the “Amendment”), effective as of November 1, 2024 (the “Effective Date”), amends that certain June 27, 2024 consulting agreement between Climb Bio, Inc. formerly known as Eliem Therapeutics, Inc. (the “Company”) and Stephen Thomas (the “Consultant”) (the “Consulting Agreement”).
WHEREAS, the Company and the Consultant desire to amend certain terms of the Consulting Agreement;
NOW, THEREFORE, in consideration of the mutual covenants and promises contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Consultant and the Company hereby agree to the following changes to the Consulting Agreement, effective as of the Effective Date:
IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the day and year set forth below:
/s/ Aoife Brennan | /s/ Stephen Thomas |
By: Aoife Brennan | By: Stephen Thomas |
Title: Chief Executive Officer |
|
Date: November 6, 2024 | Date: November 5, 2024 |